Greenberg Traurig Germany supports buy-outs, equity investments, growth investments, financing rounds, restructurings and exits in close cooperation with various other locations. The practice assists founders and investors, particularly in technology-driven areas such as medtech, biotech, software, IT and automotive. The two transaction specialists Henrik Armah and Peter Schorling lead the practice.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'Well-coordinated team, very diverse team composition.'

  • 'Henrik Armah: Excellent orderly management and moderation of large transaction processes and negotiations, very good economic and market-oriented understanding of relevant market M&A/VC clauses.'

  • ' Very experienced team. '

Key clients

  • Obvious Ventures
  • Owl Ventures
  • T.Rowe Price Associates
  • OTB Ventures
  • Vereinigte Volksbank Raiffeisenbank
  • Borg Collective
  • Digital Seals
  • BionFarming
  • Torq Partners
  • VC Worldwide (NVIDIA)
  • Matterway
  • Udacity
  • Gewobag ID

Work highlights

  • Advising NVIDIA on the sale of its stake in AImotive GmbH as part of the exit of all shareholders to the automotive group Stellantis.
  • Advising US/Israeli healthcare VC fund OrbiMed on its €15 million investment in Emergence Therapeutics, a biopharmaceutical company developing novel antibody drugs to treat cancer.

Practice head

The lawyer(s) leading their teams.

Henrik Armah, Peter Schorling